A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
Clinical trial NCT06151587 · RECRUITING
Trial details
- NCT number
- NCT06151587
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-20
- Primary completion
- 2026-06-01
- Enrollment
- 735
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.